Regulation of ion channels and arrhythmias in the ischemic heart

Joseph G Akar1, Fadi G Akar

  • 1The Cardiovascular Research Institute, Mount Sinai School of Medicine, New York, NY, USA.

Insights

Sudden cardiac death from ventricular arrhythmias in ischemic heart disease is a major concern. Understanding the heart

Area of Science:

  • Cardiovascular Physiology
  • Cardiac Electrophysiology
  • Ischemic Heart Disease

Background:

  • Ventricular arrhythmias are a primary cause of mortality in ischemic heart disease.
  • Effective treatment strategies for coronary events are hindered by complex electrophysiological changes.
  • Understanding these electrical changes during ischemia and reperfusion is critical.

Purpose of the Study:

  • To discuss key cellular and network electrophysiological changes during myocardial ischemia.
  • To highlight the link between cardiac metabolism and electrical dysfunction.
  • To improve treatment strategies for patients experiencing coronary events.

Main Methods:

  • Review of cellular electrophysiological alterations.
  • Analysis of network-level electrical changes.
  • Exploration of metabolic substrate alterations in the heart.

Main Results:

  • Identified key cellular and network electrophysiological changes associated with ischemic injury.
  • Established a link between metabolic substrate alterations and electrical dysfunction.
  • Provided insights into the dynamic nature of electrical changes during ischemia and reperfusion.

Conclusions:

  • A comprehensive understanding of electrophysiological changes is crucial for improving patient outcomes.
  • Targeting metabolic pathways may offer novel therapeutic approaches for ventricular arrhythmias.
  • Further research into the interplay between energy metabolism and cardiac electrical activity is warranted.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...